PharmaCyte Biotech Inc (PMCB)

[Triple9]

Pancreatic Cancer-Induced Diabetes: A Call To Action by Dr Richard Frank, MD

Oncology Times: October 10, 2017

http://journals.lww.com/oncology-times/Fulltext/2017/10100/Pancreatic_Cancer_Induced_Diabetes__A_Call_To.2.aspx

"Cause or Consequence?

Pancreatic cancer and diabetes are locked in a complicated dance, both pathogenetically and temporally. In the setting of a new pancreatic cancer diagnosis, the timing and course of the diabetes can be divided into three main categories:

long-standing diabetes: present for at least 3 years;

new-onset diabetes: variably defined as less than 1-3 years;

rapidly-deteriorating diabetes: sudden worsening of chronic, stable diabetes.

Each situation begs the question, “Which came first, diabetes or pancreatic cancer?” Aside from the fact that both diseases occur in the same organ, there is not a priori reason that one should directly impact the other."

Interesting read for $PMCB investors, as we have the exclusive rights from Austrianova for both indications.